Literature DB >> 11906944

Antagonism of P2X3-containing channels: commentary on Spelta et al.

Michael F Jarvis1, Edward C Burgard.   

Abstract

Mesh:

Substances:

Year:  2002        PMID: 11906944      PMCID: PMC1573255          DOI: 10.1038/sj.bjp.0704590

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  7 in total

1.  Kinetics of antagonist actions at rat P2X2/3 heteromeric receptors.

Authors:  Valeria Spelta; Lin-Hua Jiang; Annmarie Surprenant; R Alan North
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

2.  The kinetics of inhibition of nicotinic acetylcholine receptors by (+)-tubocurarine and pancuronium.

Authors:  I Wenningmann; J P Dilger
Journal:  Mol Pharmacol       Date:  2001-10       Impact factor: 4.436

3.  Microscopic kinetics and energetics distinguish GABA(A) receptor agonists from antagonists.

Authors:  M V Jones; P Jonas; Y Sahara; G L Westbrook
Journal:  Biophys J       Date:  2001-11       Impact factor: 4.033

4.  The suramin analogue NF279 is a novel and potent antagonist selective for the P2X(1) receptor.

Authors:  J Rettinger; G Schmalzing; S Damer; G Müller; P Nickel; G Lambrecht
Journal:  Neuropharmacology       Date:  2000-08-23       Impact factor: 5.250

5.  Competitive antagonism of recombinant P2X(2/3) receptors by 2', 3'-O-(2,4,6-trinitrophenyl) adenosine 5'-triphosphate (TNP-ATP).

Authors:  E C Burgard; W Niforatos; T van Biesen; K J Lynch; K L Kage; E Touma; E A Kowaluk; M F Jarvis
Journal:  Mol Pharmacol       Date:  2000-12       Impact factor: 4.436

6.  Structure-activity relationships of pyridoxal phosphate derivatives as potent and selective antagonists of P2X1 receptors.

Authors:  Y C Kim; S G Brown; T K Harden; J L Boyer; G Dubyak; B F King; G Burnstock; K A Jacobson
Journal:  J Med Chem       Date:  2001-02-01       Impact factor: 7.446

7.  Kinetic analysis of antagonist action at N-methyl-D-aspartic acid receptors. Two binding sites each for glutamate and glycine.

Authors:  M Benveniste; M L Mayer
Journal:  Biophys J       Date:  1991-03       Impact factor: 4.033

  7 in total
  2 in total

1.  2', 3'-O-(2,4,6,trinitrophenyl)-ATP and A-317491 are competitive antagonists at a slowly desensitizing chimeric human P2X3 receptor.

Authors:  Torben R Neelands; Edward C Burgard; Marie E Uchic; Heath A McDonald; Wende Niforatos; Connie R Faltynek; Kevin J Lynch; Michael F Jarvis
Journal:  Br J Pharmacol       Date:  2003-07-29       Impact factor: 8.739

Review 2.  The role of purinergic signaling in the etiology of migraine and novel antimigraine treatment.

Authors:  Marek Cieślak; Joanna Czarnecka; Katarzyna Roszek; Michał Komoszyński
Journal:  Purinergic Signal       Date:  2015-05-10       Impact factor: 3.765

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.